Makers of an investigational tuberculosis drug that has been urged for “compassionate use” approval in South Africa have applied to the European Medicines Agency to market the medicine as part of a combination therapy for multidrug-resistant tuberculosis. “If approved, bedaquiline could be one of the first drugs with a new mechanism of action for tuberculosis [...] |
Drug maker seeks approval for use against multidrug-resistant tuberculosis
↧
↧
Trending Articles
More Pages to Explore .....